Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Academy Recognizes First Distinguished Fellows of the American Academy of Audiology (DFAAA)
The American Academy of Audiology is proud to announce the inaugural cohort of Distinguished Fellows of the American Academy of Audiology (DFAAA), a prestigious honor…
The Government Is Shutdown, Now What?
Congress has failed to avert a government shutdown. The Department of Health and Human Services (HHS) is expected to face significant workforce reductions across its…
Meet the Academy Board of Directors
The American Academy of Audiology is proud to announce its Board of Directors, a group of dedicated leaders guiding the profession forward and ensuring the…